SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$43.39
-0.36 (-0.82%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-7.35%
YTD
-12.29%
Open$43.66
Previous Close$43.75
Day High$44.46
Day Low$43.14
52W High$59.68
52W Low$40.51
Volume—
Avg Volume597.3K
Market Cap2.44B
P/E Ratio—
EPS$-1.91
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.76
Below
SMA 200
$43.00
Above
RSI (14)
59.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+109.3% upside
Current
$43.39
$43.39
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 728.67M | 710.76M | 1.12B |
| Net Income | -39,071,548 | -34,300,032 | 218.96M |
| Profit Margin | -5.4% | -5.1% | 19.5% |
| EBITDA | 27.54M | 25.52M | 345.29M |
| Free Cash Flow | — | — | 147.80M |
| Rev Growth | +2.5% | +2.5% | +10.9% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |